Status:
COMPLETED
Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis Patients
Lead Sponsor:
Izmir Katip Celebi University
Conditions:
Idiopathic Pulmonary Fibrosis
Activity, Motor
Eligibility:
All Genders
18-65 years
Brief Summary
The Londrina Activities of Daily Living Protocol was first developed for Chronic Obstructive Pulmonary Disease patients and was found to be valid and reliable, but there is no validity and reliability...
Detailed Description
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by a restrictive type of breathing disorder. In IPF patients, serious limitations occur in the activities of daily liv...
Eligibility Criteria
Inclusion
- Being diagnosed with idiopathic pulmonary fibrosis (IPF) disease
- Being 18 years or older
- Being independent in daily living activities
- Being able to read and understand Turkish
Exclusion
- The patient refuses to participate in the study
- People with comorbidities that would make it impossible to perform any of the study evaluations (orthopedic pathology, uncontrolled cardiovascular or neurological conditions, psychiatric illness, etc.)
- Presence of infection in the last 3 months
- Those who show changes in their usual symptoms during the protocol
- Patients who have difficulty understanding the commands given
- Those who cannot complete all evaluations
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06049004
Start Date
November 1 2023
End Date
November 1 2024
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Izmir Katip Celebi University
Izmir, Turkey (Türkiye)